The Department of Health and Human Services' (DHHS) Office of the Inspector General (OIG) released a report on 3 January that highlights widespread violations in the reimbursement of pharmaceutical products purchased by the Medicare Part B program. The audit revealed widespread failure to submit complete-or sometimes any-data for approximately 24% of all product codes and 34% of all products. Medicare Part B is a program that administers medical insurance to US citi...